TrivarX

TrivarX EPS

The Earnings per Share (EPS) of TrivarX (TRI.AX) as of Oct 27, 2026 is -1.11 AUD.

EPS

-1.11AUD

YoY

80,636.77%

Last updated:

Earnings per Share (EPS) of TrivarX is 2026 -1.11 AUD. Earnings per Share (EPS) of TrivarX was 2025 -0.00 AUD. It decreases by 80,636.77% lower compared to the previous year.

The TrivarX EPS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EPS
Date
EPS
Jan 1, 2019
-0.01 AUD
Jan 1, 2020
-0.00 AUD
Jan 1, 2021
-0.00 AUD
Jan 1, 2022
-0.08 AUD
Jan 1, 2023
-0.01 AUD
Jan 1, 2024
-0.00 AUD
Jan 1, 2025
-0.00 AUD
Jan 1, 2026
-1.11 AUD
The TrivarX EPS history
YEAREPSYoY
-1.11AUD+80,636.77%
-0.00AUD-49.29%
-0.00AUD-70.51%
-0.01AUD-87.95%
-0.08AUD+10,518.23%
-0.00AUD-79.32%
-0.00AUD-53.39%
-0.01AUD-89.62%
-0.07AUD+50.26%
-0.05AUD+2.47%
-0.05AUD-35.90%
-0.07AUD+775.66%
-0.01AUD-75.67%
-0.03AUD-71.56%
-0.12AUD-22.14%
-0.15AUD-46.72%
-0.29AUD-35.96%
-0.45AUD-37.26%
-0.72AUD+202.65%
-0.24AUD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

TrivarX Stock analysis

What does TrivarX do? TrivarX Ltd generates revenue through its corporate health product, which provides mental well-being solutions for businesses. The company develops and commercializes mental health technology using objective biomarkers for screening, diagnosing, monitoring, and managing depression. Its consumer mobile application LUCA offers biometric assessments measuring sleep stress, activity stress, and cardiac stress, enabling users to monitor stress levels via personal wearable devices. The company focuses on early detection and screening of mental health conditions through clinical research and product development. The primary buyers of TrivarX's corporate health product are businesses seeking mental well-being solutions for their employees. The consumer application LUCA targets individuals interested in monitoring their stress levels using wearable technology. TrivarX's technology is designed to assist in the early detection and screening of mental health conditions, with a focus on depression management through objective biomarker analysis. The company's clinical research and product development activities support both business and consumer segments in the mental health technology market. TrivarX is one of the most popular companies on Eulerpool.

Frequently Asked Questions about TrivarX stock

Earnings per Share (EPS) of TrivarX is -1.11 AUD in 2026.

On Eulerpool you can find the complete historical development of Earnings per Share (EPS) TrivarX since 2006 – with annual values, charts, and detailed analysis.

Earnings per Share measures the portion of a company's profit allocated to each outstanding share. It is a key metric for assessing a company's profitability on a per-share basis.

EPS = Net Income / Shares Outstanding

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — TrivarX

All Key Metrics — TrivarX